BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 17, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 1, 2006
View Archived Issues
Targeting kallikrein for CPB in the neonate
Read More
New compound targets leukocyte elastase and demonstrates antiinflammatory activity
Read More
New compound targets glia and modulates progression of AD
Read More
Caspase inhibition may lower the risk of AD post-TBI
Read More
New agents for treating endocrine-related disorders disclosed in patent literature
Read More
Novel agents claimed for thrombotic disorders in recent Daiichi patent
Read More
Recent Tanabe patent reports new treatments for urological disorders
Read More
Fast track designation for Surfaxin in bronchopulmonary dysplasia
Read More
European orphan drug status for Intercell's Japanese encephalitis vaccine
Read More
Labopharm's once-daily tramadol NDA accepted for review
Read More
Xibrom approved for treatment of pain following cataract surgery
Read More
PTC-124 studied in new phase II trial for Duchenne muscular dystrophy
Read More
Hematide begins phase II study to treat anemia in cancer patients
Read More
NDA for NRP-104 accepted for review
Read More
Phase III study of ICA-17043 in sickle cell anemia cleared to continue
Read More
IND for ADL-5859 placed on hold
Read More
Inspire preparing to advance denufosol tetrasodium into phase III CF program
Read More
AEterna Zentaris regains rights to cetrorelix for BPH
Read More
CRx-102 shows statistically significant improvement in pain in hand osteoarthritis
Read More
Tamiflu approved in Europe for flu prevention in children aged 1 to 12 years
Read More
Naglazyme approved in Europe for MPS VI
Read More
CE Mark for Xience V stent
Read More
Fast track designation for HCV protease inhibitor SCH-503034
Read More
FDA approval for HepaGam B
Read More
MAA filing for FK-506 Modified Release Formulation
Read More
Japanese filing for YM-060 in d-IBS
Read More
Hemopure sales commence in South Africa
Read More